Pharma Tech Outlook: Pharma Tech Magazine

Q2 Solutions: Transforming Science and Data into Actionable Insights

Top 10 Genomics Solution Companies - 2019


The field of genomics has surpassed expectations over the past three decades due to massive changes in technology. These innovative technologies combined with diminished time and cost barrier of sequencing the whole human genome have not only transformed genomics research, but they also opened the door to new applications for genomics such as clinical genomics. Notably, the marriage between genomics and innovative technologies like big data, artificial intelligence, and machine learning is also making precision medicine a reality.

In addition, taking note of these telltale signs of a maturing industry, more and more corporate are also getting involved in the space. These corporations are not only from the healthcare industry but also the tech side as well— especially since genomics is equally a technology/data endeavor as it is a biological one. This trend is further accelerating the demand for innovative genomics solution and subsequent growth of genomics technology.

Understanding the changing times, Pharma Tech Outlook has compiled a list of top 10 genomics solution providers to guide organizations in harnessing the power of technology in tackling common challenges and reducing workload, increasing efficiencies, and going a step above the competition by leveraging the latest innovations. This edition also blends thought leadership, from subject-matter experts with real-life stories, on what selected vendors are doing for their clients, including exclusive insights from CIOs and CXOs. We hope this issue of the Pharma Tech Outlook helps you build the partnership you and your organization need to foster a technologically driven genome-sequencing environment.

We present to you Pharma Tech Outlook’s “Top 10 Genomics Solution Providers 2019.”

    Top Genomics Solution Companies

  • Combines AI/ML with genomic medicine to dramatically increase laboratory productivity and help clinicians to rapidly zoom in on the disease-causing varaint. The company’s secure online platform ENLITER mimics the workflow of a U.S. Board-certified medical geneticist and works with whole genome, whole exome, gene panel, and single-nucleotide polymorphism (SNP) array data to streamline how clinical labs and hospitals analyze genetic data. The critical feature that makes Breakthrough Genetics stand out in a competitive market is the company’s patent-pending technology that ensures clinical accuracy based on the latest literature to generate the highest quality report

  • Illumina applies innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for Illumina to deliver innovative, flexible, and scalable solutions to meet the needs of their customers. As a global company that places a high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, Illumina strives to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics

  • A leading global clinical trials laboratory services organization, Q2 Solutions helps biopharmaceutical, medical device, and diagnostics companies improve health through innovation that transforms science and data into actionable medical insights. Strongly positioned as the second-largest central laboratory services company in the world, the firm is a joint venture between Quintiles, the world’s largest provider of product development and integrated healthcare services and Quest Diagnostics, the world leader in diagnostic information services. The organization specializes in end-to-end laboratory services—ranging from biomarker discovery and development to application of precision medicine—and secure, enterprise-wide biospecimen and consent management solutions

  • 10x Genomics

    10x Genomics

    Established in 2012, 10x Genomics Pleasanton is a privately held company. The multi-disciplinary team in microfluidics, biochemistry, mechanical engineering, computational biology, and software has a proven track record of delivering successful commercial products built on deep technological innovation. 10x Genomics is pursuing an enormous potential market with backing from tier-one venture investors. The company is developing performance-critical algorithms, highly parallel data analysis architectures, robust web applications, and rich user interfaces and visualizations deployed to desktop and cloud on legacy-free stacks. 10X is creating products that will do for sequencing what C did for computing, bringing a leap in higher-order clarity and meaning to what is now very low-level information

  • BGI Genomics

    BGI Genomics

    BGI Genomics was founded in 1999 as a research organization to support the Human Genome Project. BGI Genomics is one of the best providers of genomic and proteomic services, now serving customers in more than 66 countries. BGI Genomics provides academic institutions, pharmaceutical companies, health care providers, and other organizations with integrated genomic and proteomic services and solutions across a broad range of applications spanning basic and translational research, drug discovery, agriculture and health care. To provide these services, they operate an extensive network of service Laboratories in China, Hong Kong, the US, and Europe

  • Congenica


    Founded in 2014, Congenica is a digital health company with a clinical decision support platform for accelerated genomic data interpretation. The software of Congenica enables genomic medicine by integrating genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients, and their families. Born out of pioneering research from the Wellcome Sanger Institute and the NHS, they are headquartered in Cambridge, UK, with a global footprint across the US and China. The company deals with Clinical genetics, Whole Genome Sequencing, Next Generation Sequencing, Genetic Variation Analysis, Rare diseases, Genomics, Digital Health, and Empowering Healthcare

  • Freenome


    Headquartered in South San Francisco, California, Freenome is a biotechnology company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238 million from investors such as RA Capital, Polaris Partners, Perceptive Advisors, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, and many others

  • Gypsy Bay Genomics

    Gypsy Bay Genomics

    Gypsy Bay Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genomic discoveries into advances in personalized clinical care and taking 'from-bench-to-bedside'​ to market. Gypsy Bay includes a team of scientists, researchers, and patient advocates who are dedicated to improving women's health on a global level with cutting edge medical technology. Their novel technology will provide early detection, categorize disease potential, and guide appropriate therapy measures to HPV-associated cancers. Founded in 2018, Gypsy Bay is a privately held company. The company deals with Genomics, Next Generation Sequencing (NGS), Bioinformatics, Consumer Genetics, DNA, and Big Data

  • Labcyte


    Labcyte is a global biotechnology company revolutionizing scientific research with acoustic liquid handling. The company’s Echo acoustic droplet ejection (ADE) technology is changing the landscape of liquid handling for life sciences. Its unparalleled speed, precision, accuracy, and cost-effective benefits is helping scientists around the world achieve better scientific data and results. Labcyte’s revolutionary acoustic liquid dispensing technology is transforming the way research is performed in laboratories across the research spectrum, from academia to pharma, from basic life sciences to translational medicine. The company’s innovations have enabled their customers to enhance personalized medicine programs, streamline DNA/RNA diagnostic testing, optimize drug discovery pipelines, and accelerate life science research

  • PierianDx


    PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. The company’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory and shared knowledge base are used by health systems, cancer centers, and commercial laboratories worldwide, driving the most integrated approach across the clinical care spectrum. PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report as they offer genomic sequencing and biomedical informatics in the laboratory with reporting and decision support at the patient’s bedside